NCT07310615Completed
Mindfulness Psychoeducation for Schizophrenia
Mindfulness-Based Psychoeducation Improves Mindfulness and Medication Adherence in Schizophrenia: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 30 Dec 2025
Brief summary (registry, in English)
This study aims to examine the effects of a mindfulness-based psychoeducation program on mindfulness levels and treatment adherence among individuals diagnosed with schizophrenia. Schizophrenia is a chronic psychiatric disorder that affects thinking, emotions, and behavior, and difficulties in adhering to prescribed treatments are commonly observed. Poor treatment adherence is associated with relapse, increased hospitalization, and reduced overall functioning. This randomized controlled study includes 40 patients assigned to either an experimental group or a control group. The experimental group receives a structured mindfulness-based psychoeducation program, while the control group receives treatment as usual without any additional intervention. Assessments are conducted before and after the intervention using a Personal Information Form, a Mindfulness Scale, and the Morisky Medication Adherence Scale.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 9 Dec 2025
- Start date
- 25 Dec 2024
- Primary completion date
- 13 Jul 2025
- Lead sponsor
- Ömer USLU
- Diseases
- Schizophrenia
- NCT number
- NCT07310615
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 25 Dec 2024 to the primary completion date, 13 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Comorbid intellectual disability, neurological disorder, or severe cognitive impairment
- Severe visual or hearing impairment preventing participation
- Any condition judged by the clinician to contraindicate participation in group sessions
Other
- Presence of acute psychotic symptoms requiring immediate hospitalization
- Substance or alcohol dependence within the last 6 months
- Participation in any mindfulness-based or psychoeducational program within the last year
Who the study is looking for
- Diagnosis of schizophrenia according to DSM-5 criteria
- Age between 18-65 years
- Being clinically stable for at least the past 3 months
- Able to communicate, read, and understand Turkish
- Receiving outpatient psychiatric follow-up
- Willingness to participate and providing informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Söke Fehime Faik Kocagöz State Hospital Coordinator of this site? Confirm its status | Aydin | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.